Methods
Patients with malignant endobronchial lesions were accepted for cryotherapy if referred with predominant symptoms attributable to endobronchial obstruction. All such patients who received cryotherapy for the first time at Harefield Hospital during October 1988-May 1989 were included in the study. Each patient was assessed clinically and had chest radiography and lung function tests shortly before the first treatment whenever possible. Subsequent assessments were made two to four weeks after each treatment, or immediately before the next treatment if this was earlier. Patients usually received three cryotherapy treatments, with a two week interval between the first and the second treatment and four weeks between the second and the third. Additional treatments were given as indicated clinically, but the data in this report refer only to the first three treatments in each patient. Occasionally the severity of a symptom such as stridor or the presence of a carinal lesion causing substantial obstruction of both main bronchi necessitated a reduction in the interval between treatments to a minimum of one week. All lesions were judged to be inoperable because of an unfavourable site, regional spread, distant metastases, or the patient's poor general health or respiratory state. A six minute walk test was performed at each assessment whenever possible."6 Arterial blood gases with the patient breathing air at rest were measured initially at the first and fourth assessments, but were attempted at all assessments in the last 17 patients.
The airway response to 2-5 mg nebulised salbutamol was measured at the first assessment, and at subsequent assessments if the patient showed an improvement initially of 15% in FEV1 or FVC after salbutamol, with an absolute improvement of at least 0-2 (FEVy) or 0 3 (FVC) L.'" An increase in MEF or PIF of 20% of the baseline value, in arterial oxygen tension (Pao2) of 1 kPa, or in six minute walk distance of 50 m or a reduction in symptom score of one unit was considered to be an improvement.
CRYOTHERAPY
Cryotherapy was performed under general anaesthesia through a rigid bronchoscope as described." The endobronchial lesion was frozen by applying a bronchial cryoprobe tip and cooled to a minimum of -70°C with circulating liquid nitrous oxide. The probe was allowed to thaw and then the lesion was refrozen. Continuous suction recovered blood and secretions from the site during the procedure. The entire procedure took about 10-15 minutes. The degree of bronchial obstruction was estimated before cryotherapy at each site in terms of percentage occluded (from 0%-completely patent-to 100% completely occluded), and whether or not there appeared to be an extrabronchial-component to the bronchial narrowing was recorded.
Data from individual patients before and after cryotherapy were compared by means of Student's paired t test. The relation between changes in various measurements with treatment were assessed by correlation coefficient.
Results
Thirty three patients (23 male) with bronchial obstruction due to malignant endobronchial tumour received cryotherapy for the first time during the study period. Details of patients and tumours are presented in tables 1 and 2.
Patients were generally old and frail; 14 (42%) were aged over 75 (range 48-89) years. No patient was refused treatment with cryotherapy if the predominant symptom was thought to be related to endobronchial obstruction and other treatment was not possible. Ten patients had received radiotherapy before being considered for cryotherapy. One patient who had had a left pneumonectomy four years previously received cryotherapy for an endobronchial malignant lesion of the right main bronchus.
All but one patient reported breathlessness as the predominant symptom before treatment. Twelve patients were breathless on minimal exertion. Almost all patients had radiographic evidence of collapse of at least one lobe. Seven patients had stridor and nine haemoptysis. Thirty patients reported cough, which disturbed sleep in five cases.
All patients had been smokers and most had flow-volume curves suggesting chronic airflow limitation. Twelve patients had an improvement in their airflow limitation after inhaling salbutamol.
Cryotherapy was performed on 81 occasions in the 33 patients. Nineteen patients had treat- ments on three occasions. Reasons for withdrawal before the third treatment were death from progressive disease (seven cases), development of cerebral metastases (three cases), and general deterioration despite treatment (two cases). Two patients had a single treatment with cryotherapy for immediate relief of symptoms before referral for radiotherapy.
Twenty three patients (700o) reported overall subjective improvement after cryotherapy. A further three patients improved initially but subsequently deteriorated. The number of patients with improvement in symptom scores and lung function following cryotherapy is shown in table 3.
Relief of dyspnoea was the most common benefit from treatment, the mean improvement in dyspnoea score between the first and the last assessment being 0-5 (p < 0 02). Stridor had resolved completely in four patients by their last assessment but it persisted or recurred in three patients. Four patients had complete resolution of haemoptysis, two after the first treatment and two after the third. In a further two patients haemoptysis improved. Cryotherapy had no effect on cough overall and changes in cough score tended not to be sustained.
According to the radiographic evidence, collapse resolved completely in two of the 23 patients and diminished in a further five.
Nineteen patients showed improvement in at least one objective measurement of lung function, and eight improved in more than one; in seven patients the improvement was in FEV,. Some patients expectorated small amounts of blood stained sputum and necrotic material for a few days after cryotherapy. There was no appreciable haemorrhage or infection and no pneumothoraces after cryotherapy. No patient required intubation or mechanical ventilation after the procedure.
Discussion
Bronchoscopic cryotherapy for endobronchial malignancy was first described in man by Sanderson et al.' Most reports so far have been retrospective and measures of improvement have tended to be qualitative rather than quantitative. Our results are broadly similar to those of others, however. 11-13
Our patients were generally old and frail and severely limited by breathlessness, and many had experienced stridor and haemoptysis. All had inoperable tumours and alternative treatments generally either had failed to control symptoms or were not possible because of the patient's general condition. The aim of any intervention in such patients is palliative, and the expected course without treatment would be progressive deterioration. Our results should be viewed against this background.
Although only the improvement in dyspnoea score and bronchial patency were statistically significant for the group as a whole, many patients had greater improvements in lung function, chest radiographs, or exercise The low incidence of complications in this study reflects our previous experience with cryotherapy. " The low incidence ofanaesthetic problems, even though many patients were elderly and hypoxaemic, with pre-existing chronic lung disease and malignant bronchial obstruction, is probably due to the short duration of general anaesthesia and the anaesthetic expertise. We have found that bronchoscopic cryotherapy provides useful palliation of dyspnoea, stridor, and haemoptysis in bronchial obstruction due to predominantly endobronchial malignancies, and that it has a low risk of adverse effects.
